SINOVENT
Founded in 2016, Sinovent is a global biopharmaceutical company focused on innovation. Sinovent is centered around global standard excellence through its advanced biotechnology platform, decades of management experience, as well as financial support. Sinovent uniquely combines its expertise in science, management and finance, to develop and promote advanced treatment methods to solve worldwide healthcare problems. Currently, the company has 12 products in development, primarily in oncology, auto-immune diseases, and infectious diseases.
SINOVENT
Industry:
Biotechnology Life Science
Founded:
2017-01-01
Address:
Suzhou, Jiangsu, China
Country:
China
Website Url:
http://www.sinovent.com.cn
Total Employee:
11+
Status:
Active
Contact:
+0512-88869230
Total Funding:
144.66 M USD
Technology used in webpage:
Domain Not Resolving Euro Pound Sterling Japanese Yen Baidu Maps
Similar Organizations
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Cerevance
Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Yidao Biotechnology
Yidao Biotechnology research and develops vaccines and biomedical products.
Current Advisors List
Founder
Investors List
CCB International
CCB International investment in Series C - Sinovent
Wen's Investment
Wen's Investment investment in Series C - Sinovent
Jiuyou Capital
Jiuyou Capital investment in Series C - Sinovent
CICC Qide
CICC Qide investment in Series C - Sinovent
Oceanpine Capital
Oceanpine Capital investment in Series C - Sinovent
Loyal Valley Capital
Loyal Valley Capital investment in Series C - Sinovent
Huaxu Investment
Huaxu Investment investment in Series C - Sinovent
Loyal Valley Capital
Loyal Valley Capital investment in Series A - Sinovent
